Search Results - "Ovchinnikov, G. A."

Diastolic heart failure: 20 years later. Сurrent issues of pathoge-nesis, diagnosis and treatment of heart failure with preserved LVEF by Ageev, F T, Ovchinnikov, A G

“…Relevant aspects of the pathogenesis, diagnosis, And treatment of heart failure with preserved LV EFThis review analyzes results of studies of the recent…”
Get more information

Рossibility of using European (HFA-PEFF) and American (H2FPEF) algorithms for diagnosing heart failure with preserved ejection fraction in Russian clinical practice by Ageev, F T, Yarovaya, E B, Ovchinnikov, A G

“…This article focuses on the significance of a unified approach to diagnosing heart failure with preserved left ventricular ejection fraction (HFpEF). The key…”
Get more information

Kinetics of the Reaction of 2-Methylpropene with Formaldehyde in the Presence of Synthetic Zeolites by Ovchinnikov, G. A., Tukhvatshin, V. S., Ilibaev, R. S., Talipov, R. F.

“…It is well known that zeolites exhibit catalytic activity in the Prins reaction. It was found that their use makes it possible to increase the selectivity of…”
Get full text

Circulating hepatocyte growth factor (HGF) in patients with comorbidity of chronic heart failure, type 2 diabetes mellitus and impaired lipid metabolism by Kochegura, Tatiana Nikolaevna, Makarevich, P I, Ovchinnikov, A G, Zhigunova, L V, Lahova, Elena Leonidovna, Shestakova, Marina Vladimirovna, Ageev, F T, Parfenova, Elena Viktorovna

“…AIM: To evaluate the plasma level of circulating heptocyte growth factor (HGF) in patients with comorbidity of post-infarction chronic heart failure (CHF),…”
Get full text

The Molecular and Cellular Mechanisms Associated with a Microvascular Inflammation in the Pathogenesis of Heart Failure with Preserved Ejection Fraction by Ovchinnikov, A G, Arefieva, T I, Potekhina, A V, Filatova, A Yu, Ageev, F T, Boytsov, S A

“…Heart failure with preserved ejection fraction (HFpEF) is a severe disease with an often unfavorable outcome. The prevalence of HFpEF continues to increase,…”
Get full text

Potential of valsartan+sacubitril therapy in hypertensive heart disease by Ovchinnikov, A. G., Gvozdeva, A. D., Potekhina, A. V., Vitsenya, M. V., Ageev, F. T.

“…The course of hypertension is often complicated by left ventricular hypertrophy (or hypertensive heart disease, HHD). The main “corridor” of natural HHD is…”
Get full text

The Role of Neprilysin Inhibitors in the Treatment of Heart Failure with Preserved Ejection Fraction by Ovchinnikov, A G, Gvozdeva, A D, Blankova, Z N, Borisov, A A, Ageev, F T

“…Clinical and hemodynamic aggravation of heart failure with preserved ejection fraction (HFpEF) is largely due to progression of left ventricular (LV) diastolic…”
Get more information

Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy by Ovchinnikov, A G, Serbul, V M, Ageev, F T

“…To evaluate the effect of ACE inhibitor enalapril, AR blocker candesartan and their combination on left ventricular hypertrophy (LVH) and content of…”
Get full text

Effects of empagliflozin on exercise tolerance and left ventricular diastolic function in patients with heart failure with preserved ejection fraction and type 2 diabetes: a prospective single-center study by Ovchinnikov, A. G., Borisov, A. A., Zherebchikova, K. Yu, Ryabtseva, O. Yu, Gvozdeva, A. D., Masenko, V. P., Ageev, F. T., Boytsov, S. A.

“…Aim. To assess the effect of the sodium-glucose transport protein 2 inhibitor empagliflozin on exercise tolerance and left ventricular (LV) diastolic function…”
Get full text

The role of diastolic transthoracic stress echocardiography with incremental workload in the evaluation of heart failure with preserved ejection fraction: indications, methodology, interpretation. Expert consensus developed under the auspices of the National Medical Research Center of Cardiology, Society of Experts in Heart Failure (SEHF), and Russian Association of Experts in Ultrasound Diagnosis in Medicine (REUDM) by Ovchinnikov, A G, Ageev, F T, Alekhin, M N, Belenkov, Yu N, Vasyuk, Yu A, Galyavich, A S, Gilyarevskiy, S R, Lopatin, Y M, Mareev, V Yu, Mareev, Yu V, Mitkov, V V, Potekhina, A V, Prostakova, T S, Rybakova, M K, Saidova, M A, Khadzegova, A B, Chernov, M Yu, Yuschuk, E N, Boytsov, S A

“…Diagnosis of heart failure with preserved ejection fraction (HFpEF) is associated with certain difficulties since many patients with HFpEF have a slight left…”
Get more information

The use of diuretics in chronic heart failure. Position paper of the Russian Heart Failure Society by Mareev, V Yu, Garganeeva, A A, Ageev, F T, Arutunov, G P, Begrambekova, Yu L, Belenkov, Yu N, Vasyuk, Yu A, Galyavich, A S, Gilarevsky, S R, Glezer, M G, Drapkina, O M, Duplyakov, D V, Kobalava, Zh D, Koziolova, N A, Kuzheleva, E A, Mareev, Yu V, Ovchinnikov, A G, Orlova, Ya A, Perepech, N B, Sitnikova, M Yu, Skvortsov, A A, Skibitskiy, V V, Chesnikova, A I

“…The document focuses on key issues of diuretic therapy in CHF from the standpoint of current views on the pathogenesis of edema syndrome, its diagnosis, and…”
Get more information

CARDIOVASCULAR COMPLICATIONS CAUSED BY CHEMOTHERAPY AND TARGETED AGENTS by Bolotina, L. V., Ovchinnikov, A. G.

“…Modern-day drug therapy has significantly increased the life expectancy of patients with breast cancer, therefore now this is the quality if the therapy itself…”
Get full text

Clinical manual for diagnosis, prevention and treatment of cardiovascular complications of cancer therapy. Parts VI-VII by Chazova, I Ye, Tyulyandin, S A, Vitsenia, M V, Panchenko, E P, Fedotkina, Yu A, Poltavskaya, M G, Gilyarov, M Yu, Martynyuk, T V, Ovchinnikov, A G, Stenina, M B, Trophimova, O P, Ageev, F T

“…Advances in treatment have led to improved survival of patients with cancer but have also resulted in untoward side effects associated with treatment…”
Get full text

Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Parts II-V by Chazova, I Ye, Tyulyandin, S A, Vitsenia, M V, Poltavskaya, M G, Gilyarov, M Yu, Martynyuk, T V, Ovchinnikov, A G, Panchenko, E P, Fedotkina, Yu A, Stenina, M B, Trophimova, O P, Ageev, F T

“…Advances in treatment have led to improved survival of patients with cancer but have also resulted in untoward side effects associated with treatment…”
Get full text

Efficacy and safety of hormone replacement therapy with levothyroxine in patients with subclinical hypothyroidism and heart failure by Ageev, F T, Blankova, Z N, Seredenina, E M, Riabtseva, O Iu, Ovchinnikov, A G, Svirida, O N

Get more information

Zofenopril in the treatment of patients with arterial hypertension and stable coronary heart disease: effects on oxidative stress and flowdependent vasodilatation by Ageev, F. T., Ovchinnikov, A. G., Plisyuk, A. G., Arzamastseva, N. E., Kulev, B. D., Kuz’mina, A. E., Patrusheva, I. F.

“…Aim. To compare the effects of ACE inhibitors zofenopril and perindopril on endothelial function and oxidative stress (OS) in patients with stable CHD and AH…”
Get full text

ASSOCIATIONS BETWEEN CLINICAL COURSE, LEFT VENTRICULAR HYPERTROPHY SEVERITY AND ACE GENE I/D POLYMORPHISM IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AND HYPERTENSIVE HEART by M. D. Smirnova, T. V. Fofanova, Z. B. Khasanova, A. G. Ovchinnikov, F. T. Ageev, A. Yu. Postnov

“…The manifold studies on ACE gene impact on left ventricular hypertrophy (LVH) development in hypertrophic cardiomyopathy (HCMP) and arterial hypertension (AH)…”
Get full text

THE CREATIVE EDUCATIONAL PROJECT AS A WAY OF CREATION OF A PROBLEM SITUATION AT LITERATURE LESSONS

“…The article considers the ways of creation of a problem situation at literature lessons — the creative educational project is considered; the description of…”
Get full text

Cardiac natriuretic peptides in patients with hypertrophic cardiomyopathy by Safrygina, Iu V, Gabrusenko, S A, Ovchinnikov, A G, Masenko, V P, Naumov, V G, Ageev, F T, Belenkov, Iu N

“…To study interrelation of main clinico-hemodynamic parameters and levels of natriuretic peptides (NUP) in patients with hypertrophic cardiomyopathy (HCMP). We…”
Get more information

The Molecular and Cellular Mechanisms Associated with a Microvascular Inflammation in the Pathogenesis of Heart Failure with Preserved Ejection Fraction by Ovchinnikov, A. G., Arefieva, T. I., Potekhina, A. V., Filatova, A. Yu, Ageev, F. T., Boytsov, S. А.

“…Heart failure withpreserved ejection fraction (HFpEF) is a severe disease with an often unfavorable outcome. The prevalence of HFpEF continues to increase,…”
Get full text